January 12, 2022
RegMed Investors’ (RMi) pre-open: cause and effect follow a weak aftermarket
January 11, 2022
RegMed Investors’ (RMi) pre-open: sector leadership, the few and the far between
January 10, 2022
RegMed Investors’ (RMi) pre-open: it’ time to take a few risks to make us smile about our portfolios
January 7, 2022
RegMed Investors’ (RMi) pre-open: will there be a finger that fits in this leaking and spiraling dyke, Hans Brinker where are you?
January 6, 2022
RegMed Investors’ (RMi) pre-open: riding the waves in which direction after two (2) sessions of carnage?
January 5, 2022
RegMed Investors’ (RMi) pre-open: a direction drifting sector
January 4, 2022
RegMed Investors’ (RMi) pre-open: first week’s a joy ride enhanced by a “January Effect”
January 3, 2022
RegMed Investors’ (RMi) pre-open: a new 2022 beginning, as 2021 is a wrap
December 22, 2021
RegMed Investors’ (RMi) pre-open: Merry Christmas coming, it’s time to be finished with portfolio timing
December 21, 2021
RegMed Investors’ (RMi) pre-open: the roller-coaster increases volatility with thinner trading volumes
December 20, 2021
RegMed Investors’ (RMi) pre-open: dive, dive and dive
December 17, 2021
RegMed Investors’ (RMi) pre-open: Quadruple Witching Friday
December 16, 2021
RegMed Investors’ (RMi) pre-open: once upon a bounce, comes a trounce?
December 15, 2021
RegMed Investors’ (RMi) pre-open: a bounce after an upcoming Fed decision?
December 14, 2021
RegMed Investors’ (RMi) pre-open: the lack of pressure for sustainability
December 13, 2021
RegMed Investors’ (RMi) pre-open: an attempt to scale the upside as sector breadth remains a concern after a mixed week
December 10, 2021
RegMed Investors’ (RMi) pre-open: I would not be making any big buys or sells
December 9, 2021
RegMed Investors’ (RMi) pre-open: a negative indication had warned me that an acknowledged drop continued to lurk
December 8, 2021
RegMed Investors’ (RMi) pre-open: quick and hi-higher highs; say bye
December 7, 2021
RegMed Investors’ (RMi) pre-open: the cell and gene therapy sector is not through correcting
December 6, 2021
RegMed Investors’ (RMi) pre-open: lean pickings
December 3, 2021
RegMed Investors’ (RMi) pre-open: a pre-occupied week
December 2, 2021
RegMed Investors’ (RMi) pre-open: bounce-back
December 1, 2021
RegMed Investors’ (RMi) pre-open: what went down, does come back up
November 30, 2021
RegMed Investors’ (RMi) pre-open: it ain’t over, investors are wary of buying dips as electronic trading contracts and controls share pricing
2 hours 37 min ago
RMi Closing Bell: Tumble
11 hours 31 min ago
RMi pre-open: Ticking
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.